Peak6 »

Crispr Therapeutics shares owned by Peak6

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Peak6 from 13F filings

Historical chart of Peak6 investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Peak6 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Peak6

Quarter filed Position value Share count Share price at filing
2025-09-30 $35M 536k 64.81
2025-06-30 $38M 786k 48.64
2025-03-31 $30M 865k 34.03
2024-12-31 $3.4M 87k 39.36

More positions owned by Peak6

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Coreweave Com Cl A Call Option (CRWV)
Apple Call Option (AAPL)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New Call Option (MSTR)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Broadcom Call Option (AVGO)

View all positions for Peak6

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics